Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reply on that "other" hub

more info from the filing:

UNITED STATES INTERNATIONAL TRADE COMMISSION

WASHINGTON, D.C.

Before the Honorable E. James Gildea

Administrative Law Judge

In the Matter of

Certain WIRELESS CONSUMER

ELECTRONICS DEVICES AND

COMPONENTS THEREOF

Investigation No. 337-TA-853

MEMORANDUM OF POINTS AND AUTHORITIES IN SUPPORT OF JOINT MOTION

TO TERMINATE THE INVESTIGATION WITH RESPECT TO RESPONDENT

KYOCERA CORPORATION

Pursuant to Commission Rule 19 C.F.R. § 210.21 (b), Complainants Technology

Properties Limited LLC, Phoenix Digital Solutions LLC and Patriot Scientific Corporation

(collectively, “TPL”) and Respondent KYOCERA CORPORATION and KYOCERA

COMMUNICATIONS, INC. (collectively, “KYOCERA”) have moved to terminate this

investigation with respect to KYOCERA, on the basis of the attached proposed MMP Portfolio

License Agreement. The parties request that this Joint Motion be granted.

Commission Rule 210.21(a) provides, in relevant part:

Any party may move at any time prior to the issuance of an initial determination on

violation of section 337 of the Tariff Act of 1930 for an order to terminate an investigation in

whole or in part as to any or all of the respondents.

The attached MMP Portfolio License Agreement has been executed by the parties. There

are no other agreements, written or oral, express or implied between the parties concerning the

subject matter of this investigation.

Settlement agreements are generally within the public interest.

See, e.g., Certain

Synchronous Dynamic Random Access Memory Devices, Microprocessors, and Products

Share
New Message
Please login to post a reply